Metabolic Reprogramming for Senescent-Cell Biology
Our Cor-Technology represents a next-generation approach to metabolic reprogramming of senescence-driven cellular dysfunction. Its novel metabolic-switch mechanism is designed to reduce reliance on glycolysis and promote fatty-acid oxidation, potentially influencing cellular signaling, epigenetic regulation, and proliferation-related pathways.
This differentiated platform supports evidence-based opportunities across pharmaceuticals, nutraceuticals, dietary supplements, functional wellness, healthy aging, and the emerging cellular beauty market—serving global expanding healthcare, wellness, beauty, and life-science sectors.
HOW IT WORKS
Targeting Personalized Biomarker
Mitochondrial Voltage
for Eradicating Cancer
and Preventing Relapse
OUR MISSION & VISION
We seek strategic partners to evaluate, license, and co-develop Cor-Technology, a novel metabolic-reprogramming platform for senescent-cell biology. Protected by a provisional patent application and supported by an expanding IP strategy, the platform enables customized research and product-development opportunities across pharmaceutical, wellness, healthy-aging, and cellular-beauty markets.
